Prostate Cancer:The early detection and early diagnosis of Prostate Cancer

• Conditions: Prostate Cancer; Cancer - Prostate

• Registration Number: ACTRN12607000452493
• Lead Sponsor: St Vincent's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: Male
• Target Recruitment: 200

Inclusion Criteria

200 male patients with clinical symptoms of Prostate cancer and other related disorders.

Exclusion Criteria

1.Amputees 2. Females 3.Local skin damage in areas of Medex Test” examination. (i.e. hands and feet)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective is to evaluate the sensitivity, specificity and total accuracy of the device, through its ability to accurately and effectively diagnose Prostate Cancer.[Before traditional diagnostic method]

Secondary Outcome Measures

Name	Time	Method
The secondary objective is to evaluate technical intra-device variability between Medex Test devices.[After traditional diagnostic method]